| Elan Corporation, a neuroscience-based biotechnology company, focuses on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and severe pain. Elans operations are principally divided into two parts: Biopharmaceuticals, and Global Services and Operations. The Biopharmaceuticals section is invloved in biopharmaceutical research, development, and commercialization activities, while the Global Services and Operations segment focuses on product development and manufacturing to provide drug delivery technologies for the pharmaceutical industry. |